Markets · 1 sources covering this

India’s New Stock Closing Auction Sparks Confusion on Debut

India’s new system to discover end-of-day market prices got off to a confusing start, with traders trying to make sense of a spike in the NSE Nifty 50 Index stemming from the shift.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
India’s New Stock Closing Auction Sparks Confusion on Debut
India’s new system to discover end-of-day market prices got off to a confusing start, with traders trying to make sense of a spike in the NSE Nifty 50 Index stemming from the shift.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/e9c88f7d70ab834034b979583446de52d70b92d5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="India’s New Stock Closing Auction Sparks Confusion on Debut"></iframe>

India’s New Stock Closing Auction Sparks Confusion on Debut

How 1 sources are covering this

India’s New Stock Closing Auction Sparks Confusion on Debut

More from Markets

Gold is still in its ‘explosive phase,’ says Deutsche Bank, as it sticks to year-end target

Chile Peso Bonds Face Pressure if Strait of Hormuz Stays Closed

Nigeria’s Top Bank Offers $1 Billion Shares Held by Bridge Firm

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’

Reader

Trust & legal

Across the network

How 1 sources are covering this

India’s New Stock Closing Auction Sparks Confusion on Debut

More from Markets

Gold is still in its &#x2018;explosive phase,&#x2019; says Deutsche Bank, as it sticks to year-end target

Chile Peso Bonds Face Pressure if Strait of Hormuz Stays Closed

Nigeria’s Top Bank Offers $1 Billion Shares Held by Bridge Firm

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it &#x2018;odd&#x2019;

Reader

Trust & legal

Across the network

Gold is still in its ‘explosive phase,’ says Deutsche Bank, as it sticks to year-end target

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’